Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Japanese multicenter observational study of geographic atrophy phenotypes in atrophic age-related macular degeneration
jRCT1030260539Not yet recruiting
- Sponsor
- Kyorin University School of Medicine
- Start
- Oct 2026
- Modality
- Vaccine mRNA → mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Open-label trial of avacincaptad pegol in geographic atrophy (GA) (2 arms), sponsored by Kyorin University School of Medicine. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
avacincaptad pegol
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on jRCT1030260539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030260539.